GELS
Gelteq Limited Ordinary SharesNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$7.13M
P/E Ratio
—
EPS
$-0.47
Beta
—
52W High
$4.11
52W Low
$0.64
50-Day MA
$0.79
200-Day MA
$1.18
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. The company is headquartered in Caulfield, Australia.
Fundamentals
| Revenue (TTM) | 413,130 |
| Gross Profit (TTM) | 297,740 |
| EBITDA | $-3.84M |
| Operating Margin | -2969.00% |
| Return on Equity | -43.00% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $1.09 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 17.26 |
| EV/Revenue | 86.83 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 59.40% |
| Shares Outstanding | $10.71M |
| Float | $4.96M |
| % Insiders | 47.53% |
| % Institutions | 0.80% |
Data last updated: 4/8/2026